AI predicts pancreatic cancer risk years in advance

An AI tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records. The findings suggest that AI-based population screening could be valuable in finding those at elevated risk for the disease and could expedite the diagnosis of a condition found all too often at advanced stages when treatment is less effective and outcomes are dismal. Currently, there are no population-based tools to screen broadly for pancreatic cancer.